Sage Therapeutics (SAGE)
(Delayed Data from NSDQ)
$14.19 USD
+0.50 (3.65%)
Updated Apr 29, 2024 03:59 PM ET
3-Hold of 5 3
F Value B Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 37% (94 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.67 | 1.52 | 9.99 |
Current Quarter Estimate | -1.70 | -2.04 | 60.00 |
Year Ago Quarter Estimate | -2.68 | -0.59 | 52.54 |
Next Quarter Estimate | -1.65 | -2.00 | 61.00 |
Next Year Estimate | -4.97 | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 27.07 | 11.30 | 17.08 |
Next Year | 24.70 | 13.20 | 8.00 |
Last 5 Years | -457.20 | 5.50 | 8.10 |
Next 5 Years | 21.90 | 22.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -5.88 |
Price/Book (MRQ) | 1.21 | 1.75 |
Price/Cash Flow (MRFY) | NA | 8.73 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -552.52% | 0.44% |
Return on Equity (TTM) | -56.81% | -9.69% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.